Key Takeaway: Johnson & Johnson is set to participate in the Bank of America 2026 Healthcare Conference. This event will provide an opportunity for the company to engage with investors and discuss its strategic initiatives. Further details about the conference and J&J's agenda are yet to be disclosed.
Price reaction · baseline $240.1 (2026-04-14 close) · hit after-hours · 1 other JNJ headline(s) in the window, move may be shared
day 0 close · peak
-0.6%
Market Sentiment Analysis
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+34%
120-day peak, hindsight
Typical move
1.6%
average across 15 past catalysts
Lead asset
Canagliflozin
Phase 3 · Diabetes Mellitus, Type 2
Full Press Release Details
NEW BRUNSWICK, N.J.--(BUSINESS WIRE)--Johnson & Johnson (NYSE: JNJ) will present at the Bank of America 2026 Healthcare Conference on Tuesday, May 12th, 2026. Management will participate in a Fireside Chat at 2:20 p.m. Eastern Time.
A live audio webcast of the presentation will be accessible through Johnson & Johnson’s Investor Relations website atwww.investor.jnj.com. An archived edition of the session will be available later that day.
The audio webcast replay will be available approximately 48 hours after the webcast.